Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -4 of 4
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
12/28/2008
 
First Published:
11/1/2001
1.
Phase II Study of Autologous Heat Shock Protein 70 Vaccine in Women With High-Risk Breast Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
Other
UCHC-01062
UCHC-1345-01, NCT00027131
Last Modified:
7/1/1997
2.
Phase I Pilot Study of Vaccination with Mucin Core Peptide and 70-kD Heat-Shock Protein for Resected Pancreatic Adenocarcinoma (Summary Last Modified 07/97)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Completed
18 and over
Other
MSKCC-96021
NCI-V96-0914
Last Modified:
12/27/2008
 
First Published:
5/1/2000
3.
Phase I Study of Vaccination Comprising Tyrosinase and gp100:209-217 Peptides Fused With OVA BiP Peptide and Heat Shock Protein 70 (HSP70) in HLA-A2 Positive Patients With Stage III or IV Melanoma (Summary Last Modified 08/2000)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Closed
Over 18
NCI
MSKCC-99036
NCI-G00-1771, NCT00005633
Last Modified:
12/28/2008
 
First Published:
2/1/2002
4.
Phase I Pilot Study of Autologous Heat Shock Protein 70 in Patients With Chronic Phase Chronic Myelogenous Leukemia
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Closed
18 and over
Other
UCHC-01117
UCHC-7659, NCI-V01-1685, NCT00030303
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute